.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
710 Labs is stocked at 758 licensed dispensaries across California, Michigan, and 5 other states, 345 of them in California, with the deepest coverage in Los Angeles, San Diego, San Francisco, Sacramento, and San Bernardino. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, 710 Labs concentrated its mix in Concentrates at 39.57% share with 11.74% year-over-year growth but a -10.12% month-over-month drop, while Flower expanded to 31.91% share with 144.85% YoY growth and a 5.10% MoM lift. Vapor Pens held 19.00% share with 5.40% YoY growth but fell -18.79% MoM, and Pre-Roll reached 9.48% share with 71.69% YoY growth yet declined -14.44% MoM; Edible shrank to 0.04% share with -94.34% YoY and -91.76% MoM. Against a brand-level YoY sales gain of 37.41% and an average price down -18.27% YoY to $31.81, the mix indicates a pivot from smaller Edible exposure toward higher-volume inhalables, with MoM softness concentrated in Concentrates and Vapor Pens.
The shift toward Flower’s 31.91% share and triple-digit 144.85% YoY rise, alongside a 5.10% MoM gain, implies 710 Labs is mitigating volatility from Concentrates’ -10.12% MoM and Vapor Pens’ -18.79% MoM through a broader inhalable portfolio at lower price points (Flower avg price $24.80 vs Concentrates $48.52). With Concentrates still leading at 39.57% share and the brand holding rank 1 in Concentrates in Colorado, the pattern points to a positioning that sustains category authority while reallocating demand into Flower and Pre-Roll, which together grew 144.85% and 71.69% YoY, to stabilize monthly swings and support share durability.
Competitive Landscape
710 Labs sits at rank #2 in California Concentrates in September 2026, a climb of 2 positions from rank #4 year over year, while holding #2 for the past three months and matching its peak rank in September 2026; Raw Garden remains ahead at #1 with a 9.37% year-over-year sales increase, and STIIIZY trails at #3 after slipping from #2 year over year despite a 6.17% sales lift, whereas Punch Extracts / Punch Edibles fell to #4 from #3 with a -7.68% change and Hashish surged to #5 from #9 with 92.03% growth; the net pattern—710 Labs improving rank by 2 positions while competitors either entrench at #1 or churn between #2–#5—implies a consolidation toward a durable #2 slot with an opportunity to pressure #1 if relative growth widens.
Notable Products
Mad Honey #13 (Bulk) led the movement in September 2026 with a -34.5% month-over-month decline, sliding to rank 4, while Hazel Nut Piff #8 Pre-Roll (1g) fell -11.2% to rank 8; in contrast, Sherb x Fumez #14 Pre-Roll (1g) rose +17.9% to rank 5. Flower concentrated the leadership with five of the top ten SKUs, including Cold Creek Kush (Bulk) at rank 1 and LMNO-Z (3.5g) at rank 9, which positions Pre-Roll gains as a tactical offset to volatility in bulk Flower. The split performance implies 710 Labs is leaning into Pre-Roll velocity to stabilize share as bulk Flower swings, suggesting near-term assortment and promo attention gravitates toward high-velocity singles over bulk formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
